Elevated risk of second primary cancer in patients with cutaneous malignant melanoma: A nationwide cohort study in Taiwan

Journal of Dermatological Science

Volumn 60, Issue 3, 2010, Pages 167-172

  Hwang, Chian Yaw ^a,b   Chen, Yi Ju ^b,c   Lin, Ming Wei ^a,b   Chen, Tzeng Ji ^a,b   Chu, Szu Ying ^a,b   Chen, Chih Chiang ^a,b   Lee, Ding Dar ^a,b   Chang, Yun Ting ^a,b   Wan, Wen Jen ^a,b   Liu, Han Nan ^a,b,d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Asian; Cancer risk; Epidemiology; Melanoma; Second primary cancer; Taiwan

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; BRAIN CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVOR; CHILD; COHORT ANALYSIS; COLON CANCER; CONNECTIVE TISSUE; EYE CANCER; FEMALE; HUMAN; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CANCER; NON MELANOMA SKIN CANCER; NOSE CAVITY CANCER; PRIMARY TUMOR; PRIORITY JOURNAL; RETROPERITONEAL CANCER; SALIVARY GLAND CANCER; SECOND CANCER; SEX DIFFERENCE; SKIN CANCER; TAIWAN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; COHORT STUDIES; DATABASES, FACTUAL; EYE NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, CONNECTIVE TISSUE; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; SKIN NEOPLASMS; TAIWAN; YOUNG ADULT;

EID: 78649529177     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.10.004     Document Type: Article

References (64)

1. Sng J., Koh D., Siong W.C., Choo T.B. Skin cancer trends among Asians living in Singapore from 1968 to 2006. J Am Acad Dermatol 2009, 61:426-432.
2. Geller A.C., Swetter S.M., Brooks K., Demierre M.F., Yaroch A.L. Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions. J Am Acad Dermatol 2007, 57:555-572.
3. Hu S., Parmet Y., Allen G., Parker D.F., Ma F., Rouhani P., et al. Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida. Arch Dermatol 2009, 145:1369-1374.
4. Tucker M.A. Melanoma epidemiology. Hematol Oncol Clin North Am 2009, 23:383-395. vii.
5. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
6. Garbe C., Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001, 14:280-290.
7. Diepgen T.L., Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002, 146(Suppl. 61):1-6.
8. Lens M.B., Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004, 150:179-185.
9. Ishihara K., Saida T., Otsuka F., Yamazaki N. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol 2008, 13:33-41.
10. Berwick M., Erdei E., Hay J. Melanoma epidemiology and public health. Dermatol Clin 2009, 27:205-214. viii.
11. Hui S.K., Tang W.Y., Wong T.W., Lau K.H., Lee S., Chong L.Y., et al. Cutaneous melanoma: a population-based epidemiology report with 989 patients in Hong Kong. Clin Exp Dermatol 2007, 32:265-267.
12. Ocana-Riola R., Martinez-Garcia C., Serrano S., Buendía-Eisman A., Ruiz-Baena C., Canela-Soler J. Population-based study of cutaneous malignant melanoma in the Granada province (Spain), 1985-1992. Eur J Epidemiol 2001, 17:169-174.
13. Cho Y.R., Chiang M.P. Epidemiology, staging (new system), and prognosis of cutaneous melanoma. Clin Plast Surg 2010, 37:47-53.
14. Katalinic A., Kunze U., Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumor stages and localization (epidemiology of skin cancer). Br J Dermatol 2003, 149:1200-1206.
15. Amerio P., Manzoli L., Auriemma M., Carbone A., Proietto G., Angelucci D., et al. Epidemiology and clinical and pathologic characteristics of cutaneous malignant melanoma in Abruzzo (Italy). Int J Dermatol 2009, 48:718-722.
16. Schmid-Wendtner M.H., Baumert J., Wendtner C.M., Plewig G., Volkenandt M. Risk of second primary malignancies in patients with cutaneous melanoma. Br J Dermatol 2001, 145:981-985.
17. Wolff J., Wollina U. Second malignancies in melanoma patients in Thuringia. J Eur Acad Dermatol Venereol 2000, 14:479-483.
18. Hui S.K., Lau K.H., Leung C.Y., Lau K.H., Lee S., Chong L.Y., et al. Cutaneous melanoma: clinical features of 32 Hong Kong Chinese patients. Hong Kong J Dermatol Venereol 2005, 13:130-140.
19. Chen Y.J., Wu C.Y., Chen J.T., Shen J.L., Chen C.C., Wang H.C. Clinicopathologic analysis of malignant melanoma in Taiwan. J Am Acad Dermatol 1999, 41:945-949.
20. Luk N.M., Ho L.C., Choi C.L., Wong K.H., Yu K.H., Yeung W.K. Clinicopathological features and prognostic factors of cutaneous melanoma among Hong Kong Chinese. Clin Exp Dermatol 2004, 29:600-604.
21. Bradford P.T. Skin cancer in skin of color. Dermatol Nurs 2009, 21:170-178.
22. Levi F., La Vecchia C., Randimbison L., Te V.C., Erler G. Incidence of invasive cancers following cutaneous malignant melanoma. Int J Cancer 1997, 72:776-779.
23. Scelo G., Boffetta P., Autier P., Hemminki K., Pukkala E., Olsen J.H., et al. Associations between ocular melanoma and other primary cancers: an international population-based study. Int J Cancer 2007, 120:152-159.
24. Gutman M., Cnaan A., Inbar M., Shafir R., Chaitchik S., Rozin R.R., et al. Are malignant melanoma patients at higher risk for a second cancer?. Cancer 1991, 68:660-665.
25. Bradford P.T., Freedman D.M., Goldstein A.M., Tucker M.A. Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 2010, 146:265-272.
26. Bhatia S., Estrada-Batres L., Maryon T., Bogue M., Chu D. Second primary tumors in patients with cutaneous malignant melanoma. Cancer 1999, 86:2014-2020.
27. Wassberg C., Thorn M., Yuen J., Ringborg U., Hakulinen T. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer 1996, 73:255-259.
28. Swerdlow A.J., Storm H.H., Sasieni P.D. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. Int J Cancer 1995, 61:773-779.
29. Spanogle J.P., Clarke C.A., Aroner S., Swetter S.M. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. J Am Acad Dermatol 2010, 62:757-767.
30. Bureau of National Health Insurance. Available at: Accessed May 31, 2010. http://www.nhi.gov.tw/english/index.asp.
31. Chang Y.T., Chen T.J., Liu P.C., Chen Y.C., Chen Y.J., Huang Y.L., et al. Epidemiological study of psoriasis in the national health insurance database in Taiwan. Acta Derm Venereol 2009, 89:262-266.
32. Huang Y.L., Chen Y.J., Lin M.W., Wu C.Y., Liu P.C., Chen T.J., et al. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study. Br J Dermatol 2009, 161:854-860.
33. Chen YJ, Wu CY, Chen TJ, Shen JL, Chu SY, Wang CB, et al. The risk of cancer in patients with psoriasis: a population based cohort study in Taiwan. J Am Acad Dermatol, in press, doi:10.1016/j.jaad.2010.04.046.
34. Taiwan Ministry of Interior. Statistical Yearbook of Interior. Available at: Accessed May 31, 2010. http://sowf.moi.gov.tw/stat/year/elist.htm.
35. Chen Y.Y., Tsai T.F. The minimal erythema dose of 311nm narrow-band UVB in Taiwanese. Dermatol Sinica 2002, 20:286-293.
36. Huang Y.L., Liao Y.L., Lee S.H., Hong H.S. Facial freckles treated by intense pulsed light- the experience of 8 cases in Taiwan. Dermatol Sinica 2003, 21:58-67.
37. Taiwan Cancer Registry. Available at: Accessed May 31, 2010. http://tcr.cph.ntu.edu.tw/main.php?Page=N1.
38. Lachiewicz A.M., Berwick M., Wiggins C.L., Thomas N.E. Epidemiologic support for melanoma heterogeneity using the Surveillance, Epidemiology, and End Results Program. J Invest Dermatol 2008, 128:243-245.
39. Baumert J., Schmidt M., Giehl K.A., Volkenandt M., Plewig G., Wendtner C., et al. Time trends in tumor thickness vary in subgroups: analysis of 6475 patients by age, tumor site and melanoma subtype. Melanoma Res 2009, 19:24-30.
40. Schallreuter K.U., Levenig C., Berger J. Cutaneous malignant melanomas with other coexisting neoplasms: a true association?. Dermatology 1993, 186:12-17.
41. MacKie R.M., Hauschild A., Eggermont A.M. Epidemiology of invasive cutaneous melanoma. Ann Oncol 2009, 20(Suppl. 6). vi1-7.
42. Koh D., Wang H., Lee J., Chia K.S., Lee H.P., Goh C.L. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-97. Br J Dermatol 2003, 148:1161-1166.
43. Cress R.D., Holly E.A. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of california cancer registry data, 1988-93. Cancer Causes Control 1997, 8:246-252.
44. Nair M.K., Varghese C., Mahadevan S., Cherian T., Joseph F. Cutaneous malignant melanoma - clinical epidemiology and survival. J Indian Med Assoc 1998, 96:19-20. 8.
45. Tanaka H., Tsukuma H., Tomita S., Ajiki W., Kitagawa T., Kinoshita N., et al. Time trends of incidence for cutaneous melanoma among the Japanese population: an analysis of Osaka Cancer Registry data, 1964-95. J Epidemiol 1999, 9:S129-S135.
46. Goggins W.B., Finkelstein D.M., Tsao H. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer 2001, 91:874-880.
47. Hegde U.P., Chakraborty N., Kerr P., Grant-Kels J.M. Melanoma in the elderly patient: relevance of the aging immune system. Clin Dermatol 2009, 27:537-544.
48. Wu Y.H., Kim G.H., Wagner J.D., Hood A.F., Chuang T.Y. The association between malignant melanoma and noncutaneous malignancies. Int J Dermatol 2006, 45:529-534.
49. Ricotti C., Bouzari N., Agadi A., Cockerell C.J. Malignant skin neoplasms. Med Clin North Am 2009, 93:1241-1264.
50. Bergman L., Nilsson B., Ragnarsson-Olding B., Seregard S. Uveal melanoma: a study on incidence of additional cancers in the Swedish population. Invest Ophthalmol Vis Sci 2006, 47:72-77.
51. Odenbro A., Gillgren P., Bellocco R., Boffetta P., Håkansson N., Adami J. The risk for cutaneous malignant melanoma, melanoma in situ and intraocular malignant melanoma in relation to tobacco use and body mass index. Br J Dermatol 2007, 156:99-105.
52. Turner B.J., Siatkowski R.M., Augsburger J.J., Shields J.A., Lustbader E., Mastrangelo M.J. Other cancers in uveal melanoma patients and their families. Am J Ophthalmol 1989, 107:601-608.
53. Garber J.E., Liepman M.K., Gelles E.J., Corson J.M., Antman K.H. Melanoma and soft tissue sarcoma in seven patients. Cancer 1990, 66:2432-2434.
54. Buckley C., Thomas V., Crow J., Houlston R., Slack J., Rustin M.H. Cancer family syndrome associated with multiple malignant melanomas and a malignant fibrous histiocytoma. Br J Dermatol 1992, 126:83-85.
55. Dunbar S.F., Marks L.B., Sober A.J., Rosenberg A., Suit H.D. Connective tissue tumors in patients with cutaneous melanoma. J Am Acad Dermatol 1994, 31:216-219.
56. Berking C., Brady M.S. Cutaneous melanoma in patients with sarcoma. Cancer 1997, 79:843-848.
57. Teppo L., Pukkala E., Saxen E. Multiple cancer - an epidemiologic exercise in Finland. J Natl Cancer Inst 1985, 75:207-217.
58. Tucker M.A., Boice J.D., Hoffman D.A. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985, 68:161-189.
59. Hussein M.R. Extracutaneous malignant melanomas. Cancer Invest 2008, 26:516-534.
60. Koomen E.R., de Vries E., van Kempen L.C., van Akkooi A.C., Guchelaar H.J., Louwman M.W., et al. Epidemiology of extracutaneous melanoma in the Netherlands. Cancer Epidemiol Biomarkers Prev 2010, 19:1453-1459.
61. Thoelke A., Willrodt S., Hauschild A., Schadendorf D. Primary extracutaneous malignant melanoma: a comprehensive review with emphasis on treatment. Onkologie 2004, 27:492-499.
62. Riou J.P., Ariyan S., Brandow K.R., Fielding L.P. The association between melanoma, lymphoma, and other primary neoplasms. Arch Surg 1995, 130:1056-1061.
63. Hall P., Rosendahl I., Mattsson A., Einhorn S. Non-Hodgkin's lymphoma and skin malignancies - shared etiology?. Int J Cancer 1995, 62:519-522.
64. Adami J., Frisch M., Yuen J., Glimelius B., Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 1995, 310:1491-1495.